TCL Archive DeVita Says NCAB Subcommittee’s Recommendation For Reshaping Organ Site Program Is “Reasonable” April 23, 1982
TCL Archive $14.7 Million Earmark Of NCI funds Trigger Protest By Advocates, Scientists October 24, 1996
TCL Archive Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said. February 18, 2005
